Selective serotonin reuptake inhibitors in the context of an ongoing analysis

Psychoanalytic Inquiry

Volumn 18, Issue 5, 1998, Pages 657-672

  Gabbard, Glen O ^a   Bartlett, Alice Brand ^a  

^a Topeka Institute for Psychoanalysis   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0032259521     PISSN: 07351690     EISSN: None     Source Type: Journal    
DOI: 10.1080/07351699809534219     Document Type: Article

References (22)

1. Azim, H. F. A. & Duncan, S. (1990), Psychoanalytic psychotherapy and psychopharmacology: Toward an integration. Psychoanal. & Psychother., 8:180-188.
2. Ballenger, J. C., Lydiard, R. B. & Turner, S. M. (1995). Panic disorder and agoraphobia. In: Treatments of Psychiatric Disorders: The Second Edition, ed. G. O. Gabbard. Washington, DC: American Psychiatric Press, pp. 1421-1452.
3. Black, B., Uhde, T. W. & Tancer, M. E. (1992), Fluoxetine for the treatment of social phobia (letter). J. Clin. Psychopharmacol., 12:293-295.
4. Brenner, C. (1992), The use of medication with patients in analysis: Panel of the New York Psychoanalytic Society, March 26, 1991. J. Clin. Psychoanal., 1:46-48.
5. Greist, J. H., Chouinard, G., DuBoff, E., Halaris, A., Kim, S. K. Koran, L., Liebowitz, M., Lydiard, R. B., Rasmussen, S., White, K. & Sikes, S. (1995), Double-blind parallel comparison of three doses of sertraline and placebo in the treatment of outpatients with obsessive-compulsive disorder. Arch. Gen. Psychiatr., 52:289-295.
6. Kagan, J. Reznick, J. S., Snidman, N., Gibbons, J. & Johnson, M. O. (1988), Childhood derivatives of inhibition and lack of inhibition to the unfamiliar. Child Development, 59:1580-1589.
7. Kantor, S. J. (1992), The use of medication with patients in analysis: Panel of the New York Psychoanalytic Society, March 26, 1991. J. Clin. Psychoanal., 1:36-40.
8. Markovitz, P. (1995), Pharmacotherapy of impulsivity, aggression, and related disorders. In: Impulsivity and Aggression, ed. E. Hollander & D. Stein. Chichester: John Wiley & Sons, pp. 263-287.
9. Normand, W. C. & Bluestone, H. (1986), The use of pharmacotherapy in psychoanalytic treatment. Contemp. Psychoanal., 22:218-234.
10. Ostow, M. (1983), The use of drugs to overcome technical difficulties in psychoanalysis. In: The Dynamics of Psychiatric Drug Therapy, ed. G. J. Sarwer-Foner. Springfield, IL: Thomas, pp. 443-470.
11. Roose, S. P. & Stern, R. H. (1995), Medication use in training cases: A survey. J. Amer. Psychoanal. Assn, 43:163-170.
12. Rosenbaum, J. F., Biederman, J., Gersten, M. & Hirshfeld, D. R. (1988), Behavioral inhibition in children of parents with panic disorder and agoraphobia: A controlled study. Arch. Gen. Psychiatr., 45:463-470.
13. Salzman, C., Woflson, A. N., Schatzber, A., Looper, S., Henke, RI, Albanse, M., Schwartz, J. & Miyawki, E. (1995), Effect of fluoxetine on anger in symptomatic volunteers with borderline personality disorder. J. Clin. Psychopharmacol., 15:23-29.
14. Sarwer-Foner, G. J. (1983), An overview of combined psychopharmacology and psychotherapy: Summary and critical comment. In: Psychopharmacology and Psychotherapy, ed. M. H. Greenhill & A. Gralnick. New York: Free Press, pp. 165-180.
15. Schneier, F. R., Chin, S. J., Hollander, E. & Liebowitz, M. R. (1992), Fluoxetine in social phobia (letter). J. Clin. Pharmacol., 12:62-63.
16. Shear, M. K., Cooper, A. M., Furman, G. L., Busch, F. N. & Shapiro, T. (1993), A psychodynamic model of panic disorder. Amer. J. Psychiatr., 150:859-866.
17. Solomon, J. L. (1995), A clinical study of the effect of the introduction of antidepressant medication on the psychoanalytic process in an analysis of long duration. J. Clin. Psychoanal., 4:169-184.
18. Tollefson, G. D., Rampey, A. H., Potvin, J. H., Jenike, M. A., Rush, A. J., Kominguez, R. A., Koran, L. M., Shear, M. K., Goodman, W. & Genduso, L. A. (1994), A multicenter investigation of fixed-dose fluoxetine in the treatment of obsessive-compulsive disorder. Arch. Gen. Psychiatr., 51:559-569.
19. Van Ameringen, M., Mancini, C. & Streiner, D. L. (1993), Fluoxetine efficacy in social phobia. J. Clin. Psychiatr., 54:27-32.
20. Wheadon, D. E., Bushnell, W. D. & Steiner, M. (1993), A fixed dose comparison of 20, 40 or 60 mg of paroxetine to placebo in the treatment of obsessive-compulsive disorder. Paper presented at the annual meeting of the American College of Neuropsychopharmacology, Maui, HI, December.
21. Wylie, H. W. & Wylie, M. L. (1987), An effect of pharmacotherapy on the psychoanalytic process: case report of a modified analysis. Amer. J. Psychiatr., 144:489-492.
22. Wyman, H. M. & Rittenberg, S. M., eds. (1992), The use of medication with patients in analysis: Panel of the New York Psychoanalytic Society, March 16, 1991. J. Clin. Psychoanal., 1:9-48.